ANGPT1 and acute kidney injury: These results are consistent with a previous study of mice with AKI secondary to folic acid administration that were shown to have decreased capillary rarefaction following treatment with recombinant Ad-Ang1 but developed increased fibrosis, an effect that may have been due to abnormal endothelial-mesenchymal cell interaction with increased resident fibroblast proliferation [32].